Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Agpat2em1flox/Cya
Common Name:
Agpat2-flox
Product ID:
S-CKO-13735
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Agpat2-flox
Strain ID
CKOCMP-67512-Agpat2-B6J-VA
Gene Name
Agpat2
Product ID
S-CKO-13735
Gene Alias
1-AGPAT 2; 2510002J07Rik; BSCL; BSCL1; LPAAB; LPAAT-beta
Background
C57BL/6JCya
NCBI ID
67512
Modification
Conditional knockout
Chromosome
2
Phenotype
MGI:1914762
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Agpat2em1flox/Cya mice (Catalog S-CKO-13735) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000028286
NCBI RefSeq
NM_026212
Target Region
Exon 2~4
Size of Effective Region
~1.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Agpat2, encoding 1-acylglycerol-3-phosphate O-acyltransferase 2, is an intermediate enzyme in triglyceride synthesis [4]. It catalyzes the acylation of lysophosphatidic acid to form phosphatidic acid (PA), a key step in the glycerol-3-phosphate pathway for the synthesis of phospholipids and triacylglycerols [1]. This process is crucial for lipid metabolism and related biological processes. Genetic models, such as gene knockout mouse models, are valuable for studying Agpat2.

In Agpat2 knockout (Agpat2-/-) mice, several significant phenotypes are observed. These mice show severe loss of adipose tissue and fatty liver [2]. When crossed with Ldlr-/-mice, Agpat2-/-Ldlr-/-mice exhibit more severe hyperlipidemia, hyperglycemia, hyperinsulinemia, liver fibrosis, and aggravated atherosclerosis compared to Ldlr-/-mice [2]. Agpat2-/-mice also completely lack both white and interscapular brown adipose tissue (iBAT), and differentiated Agpat2-/-brown adipocytes have fewer lipid-laden cells, lower abundance of key adipogenic transcription factors, increased expression of interferon-stimulated genes, and altered mitochondrial morphology [3]. In addition, adipocytes from Agpat2-/-mice have impaired adipogenesis and fewer caveolae, and abnormal lipid composition without preventing insulin signaling [5]. Postnatal cell death of adipose tissue associated with acute local inflammation leads to lipodystrophy in Agpat2-/-mice, and re-expressing human AGPAT2 in Agpat2-null mice can result in partial regeneration of adipose tissue, indicating the essential role of Agpat2 in adipocyte differentiation [6,7].

In conclusion, Agpat2 is essential for normal lipid metabolism, adipogenesis, and the maintenance of adipose tissue. Studies using Agpat2 KO mouse models have revealed its significant role in diseases such as hyperlipidemia, atherosclerosis, and lipodystrophy. Understanding Agpat2 function provides insights into the mechanisms of these disease conditions and may offer potential therapeutic targets.

References:
1. Mak, Hoi Yin, Ouyang, Qian, Tumanov, Sergey, Chen, Shuai, Yang, Hongyuan. 2021. AGPAT2 interaction with CDP-diacylglycerol synthases promotes the flux of fatty acids through the CDP-diacylglycerol pathway. In Nature communications, 12, 6877. doi:10.1038/s41467-021-27279-4. https://pubmed.ncbi.nlm.nih.gov/34824276/
2. Peng, Kenan, Chen, Xin, Pei, Kexin, Liu, Gang, Gao, Mingming. 2023. Lipodystrophic gene Agpat2 deficiency aggravates hyperlipidemia and atherosclerosis in Ldlr-/- mice. In Biochimica et biophysica acta. Molecular basis of disease, 1870, 166850. doi:10.1016/j.bbadis.2023.166850. https://pubmed.ncbi.nlm.nih.gov/37591406/
3. Tapia, Pablo J, Figueroa, Ana-María, Eisner, Verónica, Garg, Abhimanyu, Cortés, Víctor. 2020. Absence of AGPAT2 impairs brown adipogenesis, increases IFN stimulated gene expression and alters mitochondrial morphology. In Metabolism: clinical and experimental, 111, 154341. doi:10.1016/j.metabol.2020.154341. https://pubmed.ncbi.nlm.nih.gov/32810486/
4. Feng, Tiantian, Tao, Yifan, Yan, Yue, Zhang, Xing, Qiang, Jun. 2023. Transcriptional Inhibition of AGPAT2 Induces Abnormal Lipid Metabolism and Oxidative Stress in the Liver of Nile Tilapia Oreochromis niloticus. In Antioxidants (Basel, Switzerland), 12, . doi:10.3390/antiox12030700. https://pubmed.ncbi.nlm.nih.gov/36978948/
5. González-Hódar, Lila, McDonald, Jeffrey G, Vale, Goncalo, Horton, Jay D, Cortés, Víctor. 2021. Decreased caveolae in AGPAT2 lacking adipocytes is independent of changes in cholesterol or sphingolipid levels: A whole cell and plasma membrane lipidomic analysis of adipogenesis. In Biochimica et biophysica acta. Molecular basis of disease, 1867, 166167. doi:10.1016/j.bbadis.2021.166167. https://pubmed.ncbi.nlm.nih.gov/33989739/
6. Cautivo, Kelly M, Lizama, Carlos O, Tapia, Pablo J, Horton, Jay D, Cortés, Víctor A. 2016. AGPAT2 is essential for postnatal development and maintenance of white and brown adipose tissue. In Molecular metabolism, 5, 491-505. doi:10.1016/j.molmet.2016.05.004. https://pubmed.ncbi.nlm.nih.gov/27408775/
7. Agarwal, Anil K, Tunison, Katie, Vale, Goncalo, Horton, Jay D, Garg, Abhimanyu. 2023. Regulated adipose tissue-specific expression of human AGPAT2 in lipodystrophic Agpat2-null mice results in regeneration of adipose tissue. In iScience, 26, 107806. doi:10.1016/j.isci.2023.107806. https://pubmed.ncbi.nlm.nih.gov/37752957/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest